The effect of Memantine in migraine patients
Phase 3
- Conditions
- Migraine.Migraine
- Registration Number
- IRCT20171230038142N21
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 84
Inclusion Criteria
Patient satisfaction
Having a migraine criterion based on the International Headache Association criteria
Exclusion Criteria
History of addiction to any drug
Treated with herbal medicines and other palliative medicine treatments
Treated with other prophylactic drugs
Treated with corticosteroids
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of life. Timepoint: Before and two months after the start of the intervention. Method of measurement: Headache Impact Test: HIT.;Mental Health. Timepoint: Before and two months after the start of the intervention. Method of measurement: Patient Health Question questionnaire: PHQ.;Severity of headache. Timepoint: Before and two months after the start of the intervention. Method of measurement: Visual Analogue Scale.;Duration of headache per attack. Timepoint: Before and two months after the start of the intervention. Method of measurement: Question from the patient.;Number of headaches per week. Timepoint: Before and two months after the start of the intervention. Method of measurement: Question from the patient.
- Secondary Outcome Measures
Name Time Method